FIG 2.
(A) Event-free survival (EFS) and overall survival (OS) curves. Four-year EFS and OS for all patients with T-cell non-Hodgkin lymphoma were 84.7% ± 2.3% and 89.0% ± 2.0% (n = 282), respectively. (B) Overall disease-free survival (DFS) from the end of induction; 4-year DFS was 85.9% ± 2.6% (n = 203).